StreetAlpha.app
Home › Stocks › VTGN

Vistagen Therapeutics, Inc. (VTGN)

Healthcare
$0.16
▼ −12.33%
LAST CLOSE · NOV 20

Vistagen develops nasal spray medicine candidates for conditions such as social anxiety disorder and depression. It last closed at $0.16 on Nov 20, down 12.33% on the day. The next earnings report for VTGN is expected around Thu, Feb 11, 2027, after the close. For the quarter ended Sep 2026, VTGN reported EPS of -$0.24 on revenue of $138,000, with revenue down 46.5% from a year ago. Over its last 8 reports the stock moved an average of 7.1% the session after earnings.

AI Auto Pilots
Is VTGN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VTGN.

Key Stats

Last 12 months
Results
Revenue
$2.4M
+230.2% vs a year ago
Net income
−$58.9M
−2475.6% margin
EPS (diluted)
−$1.35
Operating margin
−2543.1%
−$60.6M operating income
Valuation
Market cap
$7.6M
46.2M shares
P/E
–
No P/E while losing money
Price to sales
3.2
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$10.9M
At Sep 30
Shareholder equity
$15.0M
Shares outstanding
46.2M
At Nov 10
Fiscal year endsMarch
ExchangeNasdaq
Financials history
FY2022: $1.1M$1.1MFY2022FY2023: −$227K−$227KFY2023FY2024: $1.1M$1.1MFY2024FY2025: $486K$486KFY2025FY2026: $1.3M$1.3MFY2026

From VTGN's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 13). Last 12 months adds up the four latest quarters.

Next report
Feb 11
Estimated date · After the close
Reported EPS
-$0.24
Quarter ended Sep 2026
Year ago EPS
-$0.54
Same quarter last year
Revenue
$138,000
−46.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.46Dec '24Mar 2025: -$0.44Mar '25Jun 2025: -$0.47Jun '25Sep 2025: -$0.54Sep '25Dec 2025: -$0.45Dec '25Mar 2026: -$0.37Mar '26Jun 2026: -$0.30Jun '26Sep 2026: -$0.24Sep '26Latest -$0.24
Revenue by quarter
Dec 2024: $234,000Dec '24Jun 2025: $244,000Jun '25Sep 2025: $258,000Sep '25Dec 2025: $303,000Dec '25Mar 2026: $465,000Mar '26Jun 2026: $1.5MJun '26Sep 2026: $138,000Sep '26Latest $138,000
How VTGN moved after its last 8 reports
Average move the session after a report ±7.1%
Nov 13, 2026After the close+2.1%
Aug 14, 2026Time not announced+0.5%
Jun 15, 2026After the close+20.4%
Feb 12, 2026After the close−7.2%
Nov 13, 2025After the close0.0%
Aug 7, 2025After the close+8.8%
Jun 17, 2025After the close−13.4%
Feb 13, 2025After the close+4.2%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on VTGNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Technical Analysis

VTGN · as of the Nov 20 close · updated each morning
Downtrend

The stock is 8% below its 20 day and 33% below its 50 day average. It is 153% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 38). The nearest support is the 52 week low at $0.16, and the nearest resistance the Pivot at $0.17.

Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 10.8%/day
Key levels
$5.1452 week high+3112.5%
$0.41200 day average+156.3%
$0.23100 day average+43.8%
$0.2250 day average+37.5%
$0.19Swing high (Nov 4)+18.8%
$0.1820 day average+12.5%
$0.18Pivot R1+12.5%
$0.17Pivot+6.3%
$0.1652 week low+0.0%
$0.16Last close
$0.15Pivot S1−6.3%
Indicators
RSI (14)38.39Weak, oversold below 30Neutral
MACD-0.01Below its signal lineBearish
Stochastic48.6Middle of its rangeNeutral
ADX (14)10.8No clear trend
Williams %R-99.8Oversold below −80, overbought above −20Oversold
CCI (20)-44.6Oversold below −100, overbought above 100Neutral
Rate of change−0.1%Change over 10 sessionsBearish
ATR (14)$0.02Typical daily range, 10.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for VTGN

What happened before

See how VTGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow VTGN usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How VTGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for VTGNHow many large options trades hit VTGN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

VTGN Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼17 buying vs 22 selling
  • ▼Held by funds -2.9 pts
  • ▼Funds holding -7
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding4249−14.3%
In funds' top 1000–
Held by funds22.6%25.5%−2.9 pts
New / increased5 / 1210 / 15−32.0%
Reduced / sold out10 / 1214 / 16−26.7%
Put/call ratio–0.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See VTGN institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VTGN is in one of them and how their past VTGN trades turned out.

VTGN in the AI portfolios
Loading…

VTGN News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered VTGN in an article yet. Here's the latest on the wider market.

VTGN in the news

About Vistagen Therapeutics

Vistagen is a pharmaceutical company based in South San Francisco, California, that is developing medicines for conditions including social anxiety disorder, depression, menopausal hot flashes, and cancer cachexia. Its candidates are nasal sprays designed to act on nerve receptors in the nose, with the aim of working without being absorbed into the bloodstream. The company has no approved products yet, and its candidates are being tested in clinical trials with patients.

Headquarters
South San Francisco, CA